knowledge -WSS

knowledge

author：leisure time 2025-09-28 23:44:36 - browse：7

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： How housing is health care on Long Island

focus

WSS

Community Health Systems hospitals under DOJ investigation

Regeneron agrees to White House price limits on anti

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Obesity drugs seen as possible treatment for liver disease MASH

How housing is health care on Long Island

Wikipedia

knowledge

hotspot

Moonlake's readout produced a cash windfall. Risks remain

New documents shed light on MD Anderson Cancer Institute feud

Medicare details structure of new drug price negotiation program

Food makers tried to stack nutrition panel with preferred experts

Guidelines to prevent youth baseball injuries need more muscle

Walmart eyes Medicare Advantage provider ChenMed

Psychedelics group wrestles with new pharma identity

Food makers tried to stack nutrition panel with preferred experts

Apple is now the first public company to be valued at $3 trillion

A common UTI test for kids haunts adults as a traumatic 'nightmare'

focus

A common UTI test for kids haunts adults as a traumatic 'nightmare'

PBM reform efforts get punted in Congress

Ed Silverman on new gene therapies, biosimilars, coffee, and more

A solution to the after

Ed Silverman on new gene therapies, biosimilars, coffee, and more

FDA panel endorses Alnylam’s heart drug — after picking it apart

focus

focus

hotspot

focus